Angiogenesis
New angiogenesis research from Hong Kong Baptist University, Department of Biology discussed
Published in Angiogenesis Weekly, October 26th, 2007
Research findings, 'Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor,' are discussed in a new report. According to recent research published in the British Journal of Pharmacology, "' Angiogenesis is a crucial step in tumor growth and metastasis. Ginsenoside-Rb1 (Rb1), the major active constituent of ginseng, potently inhibits angiogenesis in vivo and in vitro."
"However, the underlying mechanism remains unknown. We hypothesized that the potent anti-angiogenic protein, pigment epithelium-derived factor (PEDF), is involved in regulating the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Angiogenesis Weekly
Source: Angiogenesis Weekly (2007-10-26)
More Articles from Angiogenesis Weekly
- Angiogenesis
Findings from University of California, Department of Pediatrics broaden understanding of angiogenesis in children - Angiogenesis
New angiogenesis in children study findings have been reported from University of California, Department of Pediatrics - Angiogenesis
New angiogenesis study findings reported from University of Sheffield - Angiogenesis
Reports on angiogenesis findings from Peking Union Medical College provide new insights - Angiogenesis
Reports outline angiogenesis study findings from Shandong University, Department of Urology - Angiogenesis
Reports outline angiogenesis study results from University of California, Department of Dermatology - More from this issue of Angiogenesis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
